EXPERIMENTAL THERAPEUTICS INSTITUTE
The Experimental Therapeutics Institute serves as the interdisciplinary institutional platform for the development of new drugs, devices, and intellectual property that grow out of Mount Sinai’s basic and clinical research programs. This Institute provides a range of emerging and established technologies to Mount Sinai researchers that enable the translation of basic biological mechanisms into therapeutics. The services provided by the Institute include high-throughput screening of chemical libraries, medicinal chemistry, pharmacokinetics and pharmacodynamics and computation and systems pharmacology. Read More
Experimental Therapeutics Institute
Tel: 212-659-1710
Send e-mail
A centralized resource for the development of high-throughput screens of siRNA and small molecule libraries. Learn More
Ravi Iyengar, PhD, is Director, Experimental Therapeutics Institute, Dorothy H. and Lewis Rosenstiel Professor and Chairman, Department of Pharmacology and Systems Therapeutics, and Director and Principal Investigator, Systems Biology Center New York. Read More